| 1. |
Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ. "On-site medical care in methadone maintenance: Associations with health care use and expenditures". Journal of substance abuse treatment. 2= 0; 32: 143 (#J0124773) |
| 2. |
Berk, SI; Litwin, AH; Arnsten, JH; Du, E; Soloway, I; Gourevitch, MN. "Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: A prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment". Clinical therapeutics. 2007; 29: 131 (#J0124853) |
| 3. |
Gourevitch, Marc N; Chatterji, Pinka; Deb, Nandini; Schoenbaum, Ellie E; Turner, Barbara J. "On-site medical care in methadone maintenance: Associations with health care use and expenditures". Journal of substance abuse treatment. 2007; 32: 143 (#J0124824) |
| 4. |
Berk, SI; Litwin, AH; Du, YL; Cruikshank, G; Gourevitch, MN; Arnsten, JH. "False reduction in serum methadone concentrations by BD Vacutainer (R) serum separator tubes (SST (TM))". Clinical chemistry. 2006; 52: 1972 (#J0120808) |
| 5. |
Bruce RD; Altice FL; Gourevitch MN; Friedland GH. "Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice". Journal of acquired immune deficiency syndromes. JAIDS. 2006; 41: 563 (#J0117325) |
| 6. |
Fiellin, DA; Friedland, GH; Gourevitch, MN. "Opioid dependence: Rationale for and efficacy of existing and new treatments". Clinical infectious diseases. 2006; 43: S173 (#J0121909) |
| 7. |
Harris, Kenneth A Jr.; Arnsten, Julia H; Joseph, Herman; Hecht, Joe; Marion, Ira; Juliana, Patti; Gourevitch, Marc N. "A 5-year evaluation of a methadone medical maintenance program". Journal of substance abuse treatment. 2006; 31: 433 (#J0121851) |
| 8. |
Knowlton A; Arnsten J; Eldred L; Wilkinson J; Gourevitch M; Shade S; Dowling K; Purcell D. "Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users". Journal of acquired immune deficiency syndromes. JAIDS. 2006; 41: 486 (#J0117324) |
| 9. |
Latka MH; Metsch LR; Mizuno Y; Tobin K; Mackenzie S; Arnsten JH; Gourevitch MN. "Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: role of personal and partnership influences". Journal of acquired immune deficiency syndromes. JAIDS. 2006; 42: 222 (#J0117323) |
| 10. |
McCance-Katz EF; Rainey PM; Smith P; Morse GD; Friedland G; Boyarsky B; Gourevitch M; Jatlow P. "Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine". American journal on addictions. 2006; 15: 23 (#J0117328) |
| 11. |
McNeely J; Arnsten JH; Gourevitch MN. "Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment". Journal of substance abuse treatment. 2006; 31: 51 (#J0117322) |
| 12. |
McNeely J; Arnsten JH; Gourevitch MN. "Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey". Harm reduction journal. 2006; 3: 8 (#J0117327) |
| 13. |
Mizuno Y; Wilkinson JD; Santibanez S; Dawson Rose C; Knowlton A; Handley K; Gourevitch MN. "Correlates of health care utilization among HIV-seropositive injection drug users". AIDS Care. 2006; 18: 417 (#J0117339) |
| 14. |
Shah SS; McGowan JP; Klein RS; Converse PJ; Blum S; Gourevitch MN. "Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users". Medical science monitor. 2006; 12: MT11 (#J0117326) |
| 15. |
Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA. "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users". Clinical infectious diseases. 2005; 40 Suppl 5: S276 (#J0117334) |
| 16. |
Krantz MJ; Lowery CM; Martell BA; Gourevitch MN; Arnsten JH. "Effects of methadone on QT-interval dispersion". Pharmacotherapy. 2005; 25: 1523 (#J0117329) |
| 17. |
Litwin AH; Soloway I; Gourevitch MN. "Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities". Clinical infectious diseases. 2005; 40 Suppl 5: S339 (#J0117333) |
| 18. |
Martell BA; Arnsten JH; Krantz MJ; Gourevitch MN. "Impact of methadone treatment on cardiac repolarization and conduction in opioid users". American journal of cardiology. 2005; 95: 915 (#J0117332) |
| 19. |
Sylvestre DL; Litwin AH; Clements BJ; Gourevitch MN. "The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone". Journal of substance abuse treatment. 2005; 29: 159 (#J0117331) |
| 20. |
Tuli K; Sansom S; Purcell DW; Metsch LR; Latkin CA; Gourevitch MN; Gomez CA. "Economic evaluation of an HIV prevention intervention for seropositive injection drug users". Journal of public health management & practice. 2005; 11: 508 (#J0117330) |
| 21. |
Berg KM; Demas PA; Howard AA; Schoenbaum EE; Gourevitch MN; Arnsten JH. "Gender differences in factors associated with adherence to antiretroviral therapy". Journal of general internal medicine. 2004; 19: 1111 (#J0117335) |
| 22. |
Fishbein DA; Lo Y; Reinus JF; Gourevitch MN; Klein RS. "Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection". Journal of acquired immune deficiency syndromes. JAIDS. 2004; 37: 1367 (#J0117337) |
| 23. |
Howard AA; Arnsten JH; Gourevitch MN. "Effect of alcohol consumption on diabetes mellitus: a systematic review". Annals of internal medicine. 2004; 140: 211 (#J0068195) |
| 24. |
Karasz A; Zallman L; Berg K; Gourevitch M; Selwyn P; Arnsten JH. "The experience of chronic severe pain in patients undergoing methadone maintenance treatment". Journal of pain & symptom management. 2004; 28: 517 (#J0117336) |
| 25. |
Kunins HV; Howard AA; Klein RS; Arnsten JH; Litwin AH; Schoenbaum EE; Gourevitch MN. "Validity of a self-reported history of a positive tuberculin skin test. A prospective study of drug users". Journal of general internal medicine. 2004; 19: 1039 (#J0111629) |
| 26. |
McCance-Katz EF; Rainey PM; Smith P; Morse G; Friedland G; Gourevitch M; Jatlow P. "Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir". American journal on addictions. 2004; 13: 163 (#J0117338) |
| 27. |
Floris-Moore M; Lo Y; Klein RS; Budner N; Gourevitch MN; Moskaleva G; Schoenbaum EE. "Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy". Journal of acquired immune deficiency syndromes. JAIDS. 2003; 34: 331 (#J0068197) |
| 28. |
Krantz MJ; Martell BA; Arnsten JH; Gourevitch MN. "Medications that prolong the QT interval [Comment]". JAMA. 2003; 290: 1025 (#J0068198) |
| 29. |
Martell BA; Arnsten JH; Ray B; Gourevitch MN. "The impact of methadone induction on cardiac conduction in opiate users [Letter]". Annals of internal medicine. 2003; 139: 154 (#J0068199) |
| 30. |
Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI. "Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs". Clinical infectious diseases. 2003; 37: 1686 (#J0068196) |
| 31. |
Arno PS; Gourevitch MN; Drucker E; Fang J; Goldberg C; Memmott M; Bonuck K; Deb N; Schoenbaum E. "Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease". American journal of public health. AJPH. 2002; 92: 395 (#J0068203) |
| 32. |
Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE. "Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users". Journal of general internal medicine. 2002; 17: 377 (#J0068202) |
| 33. |
Howard AA; Klein RS; Schoenbaum EE; Gourevitch MN. "Crack cocaine use and other risk factors for tuberculin positivity in drug users". Clinical infectious diseases. 2002; 35: 1183 (#J0068201) |
| 34. |
McCance-Katz EF; Gourevitch MN; Arnsten J; Sarlo J; Rainey P; Jatlow P. "Modified directly observed therapy (MDOT) for injection drug users with HIV disease". American journal on addictions. 2002; 11: 271 (#J0068200) |
| 35. |
Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE. "Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring". Clinical infectious diseases. 2001; 33: 1417 (#J0068205) |
| 36. |
Gourevitch MN. "Interactions between HIV-related medications and methadone: an overview. Updated March 2001". Mount Sinai journal of medicine. 2001; 68: 227 (#J0068207) |
| 37. |
Klein RS; Gourevitch MN; Teeter R; Schoenbaum EE. "The incidence of tuberculosis in drug users with small tuberculin reaction sizes". International journal of tuberculosis & lung disease. 2001; 5: 707 (#J0068206) |
| 38. |
Laine C; Hauck WW; Gourevitch MN; Rothman J; Cohen A; Turner BJ. "Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs". JAMA. 2001; 285: 2355 (#J0068210) |
| 39. |
Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC. "Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program". Journal of urban health. 2001; 78: 550 (#J0068204) |
| 40. |
Gourevitch MN; Friedland GH. "Interactions between methadone and medications used to treat HIV infection: a review". Mount Sinai journal of medicine. 2000; 67: 429 (#J0068211) |
| 41. |
Berger AR; Schaumburg HH; Gourevitch MN; Freeman K; Herskovitz S; Arezzo JC. "Prevalence of peripheral neuropathy in injection drug users". Neurology. 1999; 53: 592 (#J0068214) |
| 42. |
Gourevitch MN; Hartel D; Selwyn PA; Schoenbaum EE; Klein RS. "Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis". AIDS. 1999; 13: 2069 (#J0068212) |
| 43. |
Gourevitch MN; Friedland GH. "Methadone and antiretroviral medications, part I". AIDS clinical care. 1999; 11: 30 (#J0068209) |
| 44. |
Gourevitch MN; Friedland GH. "Methadone and antiretroviral medications, part II". AIDS clinical care. 1999; 11: 37, 43, 45 (#J0068208) |
| 45. |
Gourevitch MN; Teeter R; Schoenbaum EE; Klein RS. "Self-assessment of tuberculin skin test reactions by drug users with or at risk for human immunodeficiency virus infection". International journal of tuberculosis & lung disease. 1999; 3: 321 (#J0068215) |
| 46. |
Gourevitch MN; Hartel D; Tenore P; Freeman K; Marion I; Hecht J; Lowinson J. "Three oral formulations of methadone. A clinical and pharmacodynamic comparison". Journal of substance abuse treatment. 1999; 17: 237 (#J0068213) |
| 47. |
Webber MP; Schoenbaum EE; Gourevitch MN; Buono D; Klein RS. "A prospective study of HIV disease progression in female and male drug users". AIDS. 1999; 13: 257 (#J0068216) |
| 48. |
de Asis ML; Rosenstreich DL; Chang CJ; Gourevitch MN; Small CB. "Effect of prior hepatitis B infection on serum IgE levels in patients with human immunodeficiency virus infection". Annals of allergy, asthma & immunology. 1998; 80: 35 (#J0068222) |
| 49. |
Gourevitch MN; Alcabes P; Wasserman WC; Arno PS. "Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis". International journal of tuberculosis & lung disease. 1998; 2: 531 (#J0068220) |
| 50. |
Klein RS; Gourevitch MN. "Overview of HIV and AIDS: biology and epidemiology of the virus". Gastrointestinal endoscopy clinics of North America. 1998; 8: 751 (#J0068219) |
| 51. |
Munsiff SS; Alpert PL; Gourevitch MN; Chang CJ; Klein RS. "A prospective study of tuberculosis and HIV disease progression". Journal of acquired immune deficiency syndromes & human retrovirology. 1998; 19: 361 (#J0068217) |
| 52. |
Selwyn PA; Pumerantz AS; Durante A; Alcabes PG; Gourevitch MN; Boiselle PM; Elmore JG. "Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients". AIDS. 1998; 12: 885 (#J0068221) |
| 53. |
Webber MP; Schoenbaum EE; Gourevitch MN; Buono D; Chang CJ; Klein RS. "Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users". Epidemiology. 1998; 9: 613 (#J0068218) |
| 54. |
Alpert PL; Munsiff SS; Gourevitch MN; Greenberg B; Klein RS. "A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival". Clinical infectious diseases. 1997; 24: 661 (#J0068223) |
| 55. |
Herman M; Gourevitch MN. "Integrating primary care and methadone maintenance treatment: implementation issues". Journal of addictive diseases. 1997; 16: 91 (#J0068225) |
| 56. |
Klein RS; Gourevitch MN. "Reliability of anergy skin testing in persons with HIV infection [Comment]". American journal of respiratory & critical care medicine. 1997; 155: 1490 (#J0068224) |
| 57. |
Gourevitch MN. "The epidemiology of HIV and AIDS. Current trends". Medical clinics of North America. 1996; 80: 1223 (#J0068227) |
| 58. |
Gourevitch MN; Hartel D; Schoenbaum EE; Klein RS. "Lack of association of induration size with HIV infection among drug users reacting to tuberculin". American journal of respiratory & critical care medicine. 1996; 154: 1029 (#J0068228) |
| 59. |
Gourevitch MN; Hartel D; Schoenbaum EE; Selwyn PA; Davenny K; Friedland GH; Klein RS. "A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY". American journal of public health. AJPH. 1996; 86: 1112 (#J0068229) |
| 60. |
Gourevitch MN; Wasserman W; Panero MS; Selwyn PA. "Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program". Journal of addictive diseases. 1996; 15: 93 (#J0068231) |
| 61. |
Schoenbaum EE; Hartel DM; Gourevitch MN. "Needle exchange use among a cohort of injecting drug users". AIDS. 1996; 10: 1729 (#J0068226) |
| 62. |
Gourevitch MN. "Directly observed therapy: the medicine works [Editorial]". Journal of public health management & practice. 1995; 1: ix (#J0068230) |
| 63. |
Gourevitch MN; Klein RS; Schoenbaum EE. "Neurosyphilis in patients with human immunodeficiency virus infection [Letter]". New England journal of medicine. 1995; 332: 1170 (#J0068232) |
| 64. |
Gourevitch MN; Selwyn PA; Davenny K; Buono D; Schoenbaum EE; Klein RS; Friedland GH. "Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users". Annals of internal medicine. 1993; 118: 350 (#J0068233) |
| 65. |
Gourevitch, M; Lipkin, M; Bryan, JA. "ACCESS TO HEALTH-CARE". Annals of internal medicine. 1990; 113: 478 (#J0042950) |
